Assessment of treatment response with fulvestrant (F) 500 mg in standard clinical practice through a retrospective study: NCT01509625.
Isabel Blancas
No relevant relationships to disclose
Manuel Ruiz-Borrego
No relevant relationships to disclose
Javier Salvador Bofill
No relevant relationships to disclose
Veronica Conde
No relevant relationships to disclose
Francisco Carabantes
No relevant relationships to disclose
Juan L. Bayo
No relevant relationships to disclose
Ana Jaen
No relevant relationships to disclose
Elisabeth Perez Ruiz
No relevant relationships to disclose
MarĂa del Mar Santiago
No relevant relationships to disclose
Jose Manuel Baena
No relevant relationships to disclose
Vicente Villareal
No relevant relationships to disclose
Antonia Martinez Guisado
No relevant relationships to disclose
Luis de la Cruz Merino
No relevant relationships to disclose
Pedro Rodriguez
No relevant relationships to disclose
Evelyn Reyes
Employment or Leadership Position - AstraZeneca
Rosana Cajal
Employment or Leadership Position - AstraZeneca
Mayte Delgado
No relevant relationships to disclose
Encarnacion Gonzalez Flores
No relevant relationships to disclose
Angel Inoriza
No relevant relationships to disclose
Pedro Sanchez Rovira
No relevant relationships to disclose